Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:CBLI

Cleveland BioLabs (CBLI) Stock Price, News & Analysis

Cleveland BioLabs logo

About Cleveland BioLabs Stock (NASDAQ:CBLI)

Key Stats

Today's Range
N/A
50-Day Range
$2.20
$4.34
52-Week Range
N/A
Volume
3,245 shs
Average Volume
271,922 shs
Market Capitalization
$6 thousand
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive CBLI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cleveland BioLabs and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

CBLI Stock News Headlines

Cleveland Construction News
Goldman Sachs just told you what to buy (most people missed it)
Goldman Sachs just revealed that 40% of AI data centers will be crippled by electricity shortages by 2027 - not chips, not funding, but power. Demand is growing 15% per year and the grid can't keep up. One small company makes the exact equipment these data centers need. They're sitting on $1.5 billion in orders, their hardware is already inside Musk's Colossus, and the stock still trades like a name nobody's heard of. Analyst Dylan Jovine is releasing the ticker for free.tc pixel
Best Hospitals in Cleveland, OH
Cleveland Clinic Rehabilitation Hospital
Getting Around Cleveland
See More Headlines

CBLI Stock Analysis - Frequently Asked Questions

Cleveland BioLabs, Inc. (NASDAQ:CBLI) announced its quarterly earnings results on Friday, May, 15th. The biotechnology company reported ($0.05) earnings per share for the quarter. The biotechnology company had revenue of $0.16 million for the quarter.

Based on aggregate information from My MarketBeat watchlists, some other companies that Cleveland BioLabs investors own include Inovio Pharmaceuticals (INO), OPKO Health (OPK), Sorrento Therapeutics (SRNE), Dynavax Technologies (DVAX), Novavax (NVAX) and BioCryst Pharmaceuticals (BCRX).

Company Calendar

Last Earnings
5/15/2020
Today
6/15/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:CBLI
CIK
1318641
Fax
N/A
Employees
4
Year Founded
2003

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$2.40 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-32.84%
Return on Assets
-31.29%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
45.93
Quick Ratio
45.93

Sales & Book Value

Annual Sales
$260 thousand
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.87 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
15,479,000
Free Float
N/A
Market Cap
$6 thousand
Optionable
Not Optionable
Beta
0.70

Social Links

Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

This page (NASDAQ:CBLI) was last updated on 6/15/2026 by MarketBeat.com Staff.
From Our Partners